In BC, decreased miR-206 expression is associated with advanced clinical stage and lymph node metastasis, and miR-206 overexpression in ER-positive cell lines markedly impaired EMT, migration, invasion, and inhibited TGFB1 transcription and aTGF-β1 production [57]. Here, TGFB1 is linked to breast cancer.